Stock profile

PRESTIGE CONSUMER HEALTHCARE (PBH)

PBH · Latest close $45.26 as of Oct 2, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$45.26
As of Oct 2, 2026
Tracked funds holding
2 of 83
2026 Q2 13F filings
Opened / added
1 / 1
vs previous quarter
Trimmed / exited
0
vs previous quarter

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Ariel Investments2.29%4,868,711ADDED (+13.9%)
Maverick Capital0.02%50,975NEW

Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 3, 2026.

Politician trading · U.S. House

Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

Financial Screens

· Greenblatt Magic Formula — High earnings yield and high return on capital together

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Deep Value (Templeton) — Stocks that are cheap against both earnings and assets

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

Key figures

· Greenblatt Magic Formula — Earnings yield: 8.3% · Return on capital: 71.6% · Combined rank: 14

· Cash Flow (FCF) — Latest FCF: $246.4M · FCF yield: 11.2% · Positive FCF years: 3

· Deep Value (Templeton) — P/E: 11.58 · P/B: 1.17 · Latest EPS: 3.91 · Dividend yield: 0.0%

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.24 · Operating cash flow: $257.6M · Net income: $190.3M

· Shareholder Yield — Shareholder yield: 7.1% · of which dividends: 0.0% · of which buybacks: 7.1%

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.